Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)

0.6058
Delayed Data
As of Jun 24
 -0.0679 / -10.45%
Today’s Change
0.58
Today|||52-Week Range
8.50
-87.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
AssetsCash14.5M22.5M85.6M25.4M
 
 
 
 
 
Short Term Investment Cash-6.0M7.9M63.2M-58.7M
 
 
 
 
 
Cash & Short Term Investments64.7M74.5M123.7M105.5M
 
 
 
 
 
 
ReceivablesReceivables2.4M300.0K0.000.00
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets3.2M1.9M3.1M4.4M
 
 
 
 
 
Current Assets70.4M76.7M126.8M109.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--1.8M----
 
 
Depreciation---752.0K----
 
 
Other Assets49.0K50.0K50.0K50.0K
 
 
 
 
 
Total Assets71.3M77.7M128.5M117.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.1M663.0K3.2M2.7M
 
 
 
 
 
Short Term Debt0.000.00343.0K355.0K
 
 
 
Accrued Expenses4.6M6.9M7.1M8.0M
 
 
 
 
 
Other Current Liabilities4.6M6.9M7.2M8.1M
 
 
 
 
 
Other Liabilities7.5M10.2M11.8M13.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt--0.00424.0K4.9M
 
 
 
Other Liabilities81.0K72.0K0.000.00
 
 
 
Total Liabilities7.6M10.3M12.2M17.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity63.7M67.4M116.3M99.6M
 
 
 
 
 
Total Shareholder Equity63.7M67.4M116.3M99.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding22.1M24.1M28.8M28.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.